Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV

Combination therapy with ledipasvir and sofosbuvir (LDV/SOF), direct-acting antiviral agents, is highly effective against hepatitis C virus genotype 1 infection. Although LDV/SOF is safer than conventional treatment, reports have indicated that LDV/SOF was discontinued in certain cases due to severe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intern Med
Päätekijät: Tadokoro, Tomoko, Morishita, Asahiro, Fujita, Koji, Oura, Kyoko, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Masaki, Tsutomu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Society of Internal Medicine 2017
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938499/
https://ncbi.nlm.nih.gov/pubmed/29279506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.9744-17
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia